These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8858393)

  • 21. Visual erotic stimulation test for initial screening of psychogenic erectile dysfunction: a reliable noninvasive alternative?
    Martins FE; Reis JP
    J Urol; 1997 Jan; 157(1):134-9. PubMed ID: 8976235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Etiopathology of impotence in diabetics].
    Codaccioni JL; Conte-Devolx B; Branchereau A; Conte-Devolx J; Mollard C
    Journ Annu Diabetol Hotel Dieu; 1980 May; ():239-52. PubMed ID: 7401425
    [No Abstract]   [Full Text] [Related]  

  • 23. [Measuring nocturnal tumescence--value in diagnosis of impotence].
    Suter S; John H
    Ther Umsch; 1998 Jun; 55(6):361-4. PubMed ID: 9658977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erectile impotence--it can be highly treatable.
    Martin LM
    Geriatrics; 1980 Dec; 35(12):79-83. PubMed ID: 7429163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Norepinephrine involvement in response to intracorporeal injection of papaverine in psychogenic impotence.
    Kim SC; Oh MM
    J Urol; 1992 Jun; 147(6):1530-2. PubMed ID: 1593682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of penile Doppler sonography in impotent diabetics].
    Giordanengo F; Pignoli P; De Carlis L; Soleri V; Franch L
    Minerva Med; 1981 Dec; 72(49):3341-4. PubMed ID: 7312210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neurologic and neurophysiologic studies of impotent patients].
    Scheiber-Nogueira MC
    Ann Urol (Paris); 1993; 27(3):131-5. PubMed ID: 8352573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The patient with erectile dysfunction.
    Tomlinson J
    Practitioner; 2005 Feb; 249(1667):104, 106, 108 passim. PubMed ID: 15724529
    [No Abstract]   [Full Text] [Related]  

  • 29. Diagnostic value of nitric oxide, lipoprotein(a), and malondialdehyde levels in the peripheral venous and cavernous blood of diabetics with erectile dysfunction.
    El-Latif MA; Makhlouf AA; Moustafa YM; Gouda TE; Niederberger CS; Elhanbly SM
    Int J Impot Res; 2006; 18(6):544-9. PubMed ID: 16625232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bulbocavernosus-reflex latencies and pudendal nerve SSEP compared to penile vascular testing in 669 patients with erectile failure and other sexual dysfunction.
    Fabra M; Porst H
    Int J Impot Res; 1999 Jun; 11(3):167-75. PubMed ID: 10404286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of nocturnal penile tumescence in the differential diagnosis of sexual impotence. A quantitative study.
    Fisher C; Schiavi RC; Edwards A; Davis DM; Reitman M; Fine J
    Arch Gen Psychiatry; 1979 Apr; 36(4):431-7. PubMed ID: 426610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for neurologic disease in impotent patients.
    Grotta J; Lipshultz L; Hankins L; Roongta S; McLaughlin E; Vital D
    Tex Med; 1985 Oct; 81(10):44-7. PubMed ID: 4060079
    [No Abstract]   [Full Text] [Related]  

  • 33. ["Hidden" organic causes of impotence. Diagnostic methods and critical evaluation of their responsibility].
    Buvat J; Buvat-Herbaut M; Lemaire A; Marcolin G
    Ann Urol (Paris); 1988; 22(1):36-47. PubMed ID: 3285764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impotence.
    Johnson J
    Br J Psychiatry; 1975; Spec No 9():206-11. PubMed ID: 171019
    [No Abstract]   [Full Text] [Related]  

  • 35. An evaluation of the Minnesota Multiphasic Personality Inventory as a discriminator of primary organic and primary psychogenic impotence in diabetic males.
    Jefferson TW; Glaros A; Spevack M; Boaz TL; Murray FT
    Arch Sex Behav; 1989 Apr; 18(2):117-26. PubMed ID: 2712688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The relationship of cavernous oxygen tension with erectile dysfunction of vascular origin].
    Romero-Tejada JC; Fernández Borrell A; Fernández Arjona M; Pereira Sanz I
    Arch Esp Urol; 1998 Nov; 51(9):919-22. PubMed ID: 9887565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A trial of the use pf prostaglandin E1 (Edex, Caverject) for the diagnosis and treatment of erectile dysfunction].
    Kovalev VA; Koroleva SV
    Urol Nefrol (Mosk); 1997; (2):41-4. PubMed ID: 9206883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nocturnal penile tumescence and rigidity monitor--use in a family practice.
    Stoliar L; Shvartzman P; Horenstein I
    Isr J Med Sci; 1995 Jun; 31(6):359-64. PubMed ID: 7607856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Erectile response to intracavernous injection of linsidomine in 38 impotent patients. Comparison with prostaglandin E1].
    Lemaire A; Buvat J
    Prog Urol; 1998 Jun; 8(3):388-91. PubMed ID: 9689672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence based assessment of erectile dysfunction.
    Broderick GA
    Int J Impot Res; 1998 May; 10 Suppl 2():S64-73; discussion S77-9. PubMed ID: 9647964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.